Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Purchase | 2024-04-17 8:21 pm | Outlook Therapeutics Inc. | OTLK | Syntone Ventures LLC 10% Owner | 714,286 | $0 | $0 | 2,776,867 (Direct) | View |
| 2024-03-28 Purchase | 2024-03-29 10:39 am | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 1,882 | $11.82 | $22,242 | 5,049 (Direct) | View |
| 2024-03-07 Purchase | 2024-03-11 4:43 pm | Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER | 62,484 | $0.42 | $26,243 | 808,459 (Direct) | View |
| 2023-04-20 Sale | 2023-04-21 9:05 pm | Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer | 520,000 | $1.135 | $590,200 | 653,058 (Direct) | View |
| 2023-01-20 Sale | 2023-01-24 8:08 pm | Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer | 267,000 | $1.11 | $296,370 | 745,975 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 8:05 pm | Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer | 164,155 | $1.2411 | $203,726 | 1,012,975 (Direct) | View |
| 2022-10-07 Purchase | 2022-10-11 5:09 pm | Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director | 30,000 | $1.29 | $38,700 | 68,000 (Direct) | View |
| 2022-10-06 Purchase | 2022-10-11 5:05 pm | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 33,343 | $1.2878 | $42,940 | 63,343 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-20 Option Award | 2024-03-22 5:00 pm | N/A 2034-03-20 | Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO AND PRESIDENT | 455,000 | $0 | 455,000 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:00 pm | N/A 2034-03-20 | Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:00 pm | N/A 2034-03-20 | Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CHIEF FINANCIAL OFFICER | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-18 Option Award | 2024-03-20 5:20 pm | 2024-03-18 2029-03-18 | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 5,764,285 | $0 | 9,266,645 (Indirect) | View |
| 2024-03-07 Option Award | 2024-03-08 4:30 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Haller Julia A Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:18 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Huang Andong Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:14 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:13 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:11 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:08 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:06 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:04 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-06 08:16 am | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 370,282 | $0 | 370,282 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:15 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Haller Julia A Director | 210,225 | $0 | 210,225 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:14 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Huang Andong Director | 191,113 | $0 | 191,113 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:13 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director | 210,225 | $0 | 210,225 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:07 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 358,337 | $0 | 358,337 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:06 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director | 372,671 | $0 | 372,671 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:05 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director | 286,670 | $0 | 286,670 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-19 5:41 pm | N/A 2033-04-17 | Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer | 192,143 | $0 | 192,143 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-19 5:41 pm | N/A 2033-04-17 | Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer | 192,143 | $0 | 192,143 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-19 5:40 pm | N/A 2033-04-17 | Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President | 257,143 | $0 | 257,143 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:50 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:49 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Haller Julia A Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:48 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Huang Andong Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:47 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:46 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:45 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:44 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:43 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2022-12-28 Option Award | 2022-12-29 5:01 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 14,230,418 | $0.8784 | 70,047,204 (Indirect) | View |
| 2022-10-05 Option Award | 2022-10-07 4:39 pm | N/A 2032-10-05 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 71,998 | $0 | 71,998 (Direct) | View |